Compass Pathways stock holds Buy rating on positive depression trial
Compass Pathways stock holds Buy rating on positive depression trialSource: Investing.com
التصنيف Investing News
أخبار الاستثمار والأسواق المالية من موقع Investing.com
H.C. Wainwright maintains buy rating on Sana Biotechnology stock
H.C. Wainwright maintains buy rating on Sana Biotechnology stockSource: Investing.com
H.C. Wainwright reiterates buy rating on Redwire stock after acquisition
H.C. Wainwright reiterates buy rating on Redwire stock after acquisitionSource: Investing.com
Biomea Fusion stock price target cut to $4 from $18 at H.C. Wainwright
Biomea Fusion stock price target cut to $4 from $18 at H.C. WainwrightSource: Investing.com
Cidara stock surges as H.C. Wainwright raises price target on trial data
Cidara stock surges as H.C. Wainwright raises price target on trial dataSource: Investing.com
Truist lowers Expedia stock price target on vacation rental concerns
Truist lowers Expedia stock price target on vacation rental concernsSource: Investing.com
Goldman Sachs raises Five Below stock price target on improving brand
Goldman Sachs raises Five Below stock price target on improving brandSource: Investing.com
UK may compel Google to change search rankings, offer alternatives
UK may compel Google to change search rankings, offer alternativesSource: Reuters
Oscar Health stock downgraded by Raymond James on valuation concerns
Oscar Health stock downgraded by Raymond James on valuation concernsSource: Investing.com
Morgan Stanley names Chewy its top pick for the $40bn vet clinics opportunity
Morgan Stanley names Chewy its top pick for the $40bn vet clinics opportunitySource: Investing.com
تواصل معنا اليوم لبدء إجراءات توثيق معاملتك المالية
الموقع الرسمي:
www.taxtct.com
واتساب واتصال مباشر
+44 7480 219471
البريد الإلكتروني
info@taxtct.com
جميع الحقوق محفوظة ©
All rights reserved ©